Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance

NCT04864405 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
245
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ottawa Hospital Research Institute